FLT3-ITDs have been found mostly in JMD [6] and few cases in TKD [9] with the approximation of 15–35% of AML [2], [10], [11], [12], whereas FLT3 point mutations was predominantly found in activation loop of TKD (at D835 [7] and I836 position [2]) but rare in JMD [13] with approximately 5–10% of AML patients [2], [10], [11], [12]. This evidence concerns the gene FLT3 and acute myeloid leukemia.